“…BirA catalyzes the transformation of biotin to a more reactive form, and the resultant biotin cloud reacts with primary amines of proteins in its vicinity, resulting in their covalent biotinylation (Roux et al, 2018). Subcellular compartments that have been targeted by BioID include the nuclear envelope (Kim et al, 2016b), centrosome (Antonicka et al, 2020), nucleus (preprint: Go et al, 2019), cytoplasm (Redwine et al, 2017), Golgi apparatus (Liu et al, 2018), ER (Hoffman et al, 2019), endosome, lysosome, mitochondrial matrix (Antonicka et al, 2020), cell-cell junctions (Fredriksson et al, 2015), and flagella (Kelly et al, 2020), with labeling efficiency limited in the ER (Roux et al, 2018;preprint: Go et al, 2019). Due to slow reaction kinetics, BioID requires labeling for 18-24 h to produce sufficient material for identification by MS, which can lead to off-target labeling and high background, and somewhat Genetic variants, which may occur rarely across individuals with a specific disease, can be used as the basis of PPI networks.…”